Frequent Polymorphism in BCR Exon B2 Identified in BCR-ABL Positive and Negative Individuals Using Fluorescent Hybridization Probes

Leukemia - United Kingdom
doi 10.1038/sj.leu.2401929
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Fluorescent In-Situ Hybridization (FISH) for BCR/ABL in Chronic Myeloid Leukemia After Bone Marrow Transplantation

Sao Paulo Medical Journal
Medicine
2001English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Kinase Domain Mutants of BCR Enhance BCR-Abl Oncogenic Effects

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Retraction Note: Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy